Literature DB >> 33649324

Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits.

Anastasia Noël1,2, Bénédicte Foveau1,2, Andréa C LeBlanc3,4,5.   

Abstract

Active Caspase-6 (Casp6) and Tau cleaved by Casp6 at amino acids 402 (Tau∆D402) and 421 (TauD421) are present in early Alzheimer disease intraneuronal neurofibrillary tangles, which are made primarily of filamentous Tau aggregates. To assess whether Casp6 cleavage of Tau contributes to Tau pathology and Casp6-mediated age-dependent cognitive impairment, we generated transgenic knock-in mouse models that conditionally express full-length human Tau (hTau) 0N4R only (CTO) or together with human Casp6 (hCasp6) (CTC). Region-specific hippocampal and cortical hCasp6 and hTau expression were confirmed with western blot and immunohistochemistry in 2-25-month-old brains. Casp6 activity was confirmed with TauD421 and Tubulin cleaved by Casp6 immunopositivity in 3-25-month-old CTC, but not in CTO, brains. Immunoprecipitated Tau∆D402 was detected in both CTC and CTO brains, but was more abundant in CTC brains. Intraneuronal hippocampal Tau hyperphosphorylation at S202/T205, S422, and T231, and Tau conformational change were absent in both CTC and CTO brains. A slight accumulation of Tau phosphorylated at S396/404 and S202 was observed in Cornu Ammonis 1 (CA1) hippocampal neuron soma of CTC compared to CTO brains. Eighteen-month-old CTC brains showed rare argentophilic deposits that increased by 25 months, whereas CTO brains only displayed them sparsely at 25 months. Tau microtubule binding was equivalent in CTC and CTO hippocampi. Episodic and spatial memory measured with novel object recognition and Barnes maze, respectively, remained normal in 3-25-month-old CTC and CTO mice, in contrast to previously observed impairments in ACL mice expressing equivalent levels of hCasp6 only. Consistently, the CTC and CTO hippocampal CA1 region displayed equivalent dendritic spine density and no glial inflammation. Together, these results reveal that active hCasp6 co-expression with hTau generates Tau cleavage and rare age-dependent argentophilic deposits but fails to induce cognitive deficits, neuroinflammation, and Tau pathology.

Entities:  

Year:  2021        PMID: 33649324      PMCID: PMC7921451          DOI: 10.1038/s41419-021-03506-0

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  76 in total

1.  Caspase activation precedes and leads to tangles.

Authors:  Alix de Calignon; Leora M Fox; Rose Pitstick; George A Carlson; Brian J Bacskai; Tara L Spires-Jones; Bradley T Hyman
Journal:  Nature       Date:  2010-03-31       Impact factor: 49.962

2.  Immunoelectron microscopic and biochemical studies of caspase-cleaved tau in a mouse model of tauopathy.

Authors:  Wen-Lang Lin; Dennis W Dickson; Naruhiko Sahara
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

3.  Caspase-2 cleavage of tau reversibly impairs memory.

Authors:  Xiaohui Zhao; Linda A Kotilinek; Benjamin Smith; Chris Hlynialuk; Kathleen Zahs; Martin Ramsden; James Cleary; Karen H Ashe
Journal:  Nat Med       Date:  2016-10-10       Impact factor: 53.440

4.  The promoter of brain-specific angiogenesis inhibitor 1-associated protein 4 drives developmentally targeted transgene expression mainly in adult cerebral cortex and hippocampus.

Authors:  Mi-Young Kim; Kyu Youn Ahn; Seon Min Lee; Jeong Tae Koh; Byeong Jo Chun; Choon Sang Bae; Kee Sook Lee; Kyung Keun Kim
Journal:  FEBS Lett       Date:  2004-05-21       Impact factor: 4.124

Review 5.  Caspase-6 as a novel early target in the treatment of Alzheimer's disease.

Authors:  Andrea C LeBlanc
Journal:  Eur J Neurosci       Date:  2013-06       Impact factor: 3.386

6.  Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms.

Authors:  Emmanuel Planel; Yoshitaka Tatebayashi; Tomohiro Miyasaka; Li Liu; Lili Wang; Mathieu Herman; W Haung Yu; Jose A Luchsinger; Brian Wadzinski; Karen E Duff; Akihiko Takashima
Journal:  J Neurosci       Date:  2007-12-12       Impact factor: 6.167

7.  Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease.

Authors:  Jasmine Ramcharitar; Steffen Albrecht; Veronica M Afonso; Vikas Kaushal; David A Bennett; Andrea C Leblanc
Journal:  J Neuropathol Exp Neurol       Date:  2013-09       Impact factor: 3.685

8.  Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.

Authors:  Naruhiko Sahara; Miyuki Murayama; Boyoung Lee; Jung-Mi Park; Sarita Lagalwar; Lester I Binder; Akihiko Takashima
Journal:  Eur J Neurosci       Date:  2008-06-06       Impact factor: 3.386

9.  Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.

Authors:  Qipeng Zhang; Xiaoguang Zhang; Anyang Sun
Journal:  Acta Neuropathol       Date:  2009-02-04       Impact factor: 17.088

10.  A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals.

Authors:  Peng Liu; Benjamin R Smith; Michelle L Montonye; Lisa J Kemper; Kailee Leinonen-Wright; Kathryn M Nelson; LeeAnn Higgins; Candace R Guerrero; Todd W Markowski; Xiaohui Zhao; Ashley J Petersen; David S Knopman; Ronald C Petersen; Karen H Ashe
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

View more
  2 in total

Review 1.  Cell Death Related Proteins Beyond Apoptosis in the CNS.

Authors:  Bazhena Bahatyrevich-Kharitonik; Rafael Medina-Guzman; Alicia Flores-Cortes; Marta García-Cruzado; Edel Kavanagh; Miguel Angel Burguillos
Journal:  Front Cell Dev Biol       Date:  2022-01-14

2.  NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.

Authors:  Ena Španić; Lea Langer Horvat; Katarina Ilić; Patrick R Hof; Goran Šimić
Journal:  Cells       Date:  2022-07-17       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.